Basic Study
Copyright ©The Author(s) 2016.
World J Virol. Feb 12, 2016; 5(1): 14-22
Published online Feb 12, 2016. doi: 10.5501/wjv.v5.i1.14
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Correlogram and partial correlogram for a case structure control used for autoregressive integrated moving average model. A: ACF; B: Partial ACF. ACF: Autocorrelation function.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Residual plots for the final autoregressive integrated moving average (2, 1, 7) model of hepatitis C virus seroprevalence among volunteer blood donors in Libya, 2008-2013. A: ACF; B: Partial ACF. Lines indicate 95%CI. ACF: Autocorrelation function.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Number of observed and forecast hepatitis C virus seropositive volunteers among blood donors in Libya, 2008-2013. Date: Period of observation (months: 2008-2013); Number: Estimated number of HCV seropositive/month. UCL: Upper confidence limit; LCL: Lower confidence limit; HCV: Hepatitis C virus.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Modeled prevalence (not exclusive1) of hepatitis C virus infection by 6-year period, Libya, 2008-2055. 1Estimates assume stable risk populations and HCV infection risks and do not adjust for treatment. HCV: Hepatitis C virus.